MGF Peptide: What the Research Shows (Mechano Growth Factor)

MGF is a splice variant of the IGF-1 gene, called IGF-1Ec in humans. Resistance exercise raises its mRNA in the muscle of young men. No study has shown that an injected MGF peptide builds muscle, repairs tendon or does anything else in people, and no human trial of it exists.

The research splits in two. Several labs report that the 24-amino-acid E peptide drives muscle stem cells to multiply. Scientists at two pharmaceutical companies could not reproduce that. This page covers what MGF is, what each side found, where the evidence breaks down, and where MGF stands with FDA and WADA. It lists no doses. For the pegylated version, see our PEG-MGF page.

What is MGF?

MGF stands for mechano growth factor. The IGF-1 gene can be spliced into several forms. In humans, a 49-base insert shifts the reading frame and gives IGF-1Ec its own C-terminal tail, called the E domain (14). The mature IGF-1 region is identical in both forms (10). Researchers ascribed effects to a 24-amino-acid COOH-terminal peptide and named it MGF (16). That peptide is what labs synthesize and sellers list.

What happens to MGF in human muscle?

In one biopsy study, 10 men did exercise that damaged their muscle. Biopsies were taken before and at 6 hours, 2, 5 and 16 days. MGF mRNA rose rapidly and briefly. A longer rise in IGF-1Ea and IGF-1Eb mRNA followed. The protein patterns for MGF and IGF-1Ea were similar (1).

In another, 8 men aged 25 to 36 and 7 men aged 70 to 82 did 10 sets of 6 single-leg knee extensions at 80% of their one-repetition maximum. MGF mRNA rose 2.5 hours later in the young men but not in the older men. At rest, MGF mRNA was about 100 times lower than IGF-1Ea (2).

In rats, MGF mRNA rose first after muscle damage and fell within a few days, as IGF-1Ea rose (5). In rabbits, stretch raised both forms of IGF-1 mRNA (6). These studies measure the body’s own mRNA. They say nothing about injecting a peptide.

What does the case for the E peptide rest on?

The first report came from Goldspink’s group. The E domain raised myoblast proliferation and held back differentiation (12). Later cell studies agreed in part. In porcine satellite cells, MGF stimulated proliferation and inhibited differentiation. It also lowered MyoD, p21, myogenin and MEF2 expression (13).

In human muscle cells, the E peptide extended the proliferative life of neonatal and young adult cells but not older adult cells, and it increased fusion potential (14). In C2C12 cells, its proliferative effect was not blocked by an anti-IGF-1 receptor antibody and it did not phosphorylate Akt. That suggests a different route from mature IGF-1 (1).

The studies do not agree on differentiation. Yang and Qin reported inhibition, and Kandalla reported more fusion. A C2C12 structure-function study found that the N-terminal part of IGF1Ec promoted proliferation. The C-terminal E sequence promoted differentiation and migration (15).

What does the case against rest on?

Scientists at two pharmaceutical companies tried to reproduce it. Peptide concentrations up to 500 ng/mL did not raise the proliferation of mouse C2C12 cells or primary human myoblasts and did not block differentiation. Primary mouse muscle stem cells did not respond either. Mature IGF-1 and full-length IGF-1Eb did. They wrote that the results “call in to question whether there is a physiological role for MGF” (16).

A 2010 review found that no analogous peptide product of the Igf1 gene has been identified in cells, culture medium, tissues or body fluids (18). A 2016 receptor assay found that full-length MGF activated the IGF-1 receptor. Its EC50 was about nine times higher than IGF-1’s (7.83 against 0.86 nmol/L). The MGF peptide and a stabilized analog called Goldspink-MGF activated nothing (17).

Where does the 25% muscle growth figure come from?

It comes from Goldspink’s 2005 review. An MGF cDNA was put into a plasmid with muscle-specific regulatory sequences. After one injection into mouse muscle, mean fiber cross-sectional area rose 25% within three weeks. The review cites a US patent for the result, and a patent is not peer reviewed (4). The muscle made MGF itself from the gene, so the result says nothing about an injected peptide.

Does MGF help with aging?

The anti-aging argument comes mainly from Goldspink’s group. They argue that older muscle fails to raise MGF after exercise, which leaves the satellite cell pool unreplenished. They also report that growth hormone plus resistance exercise shifts IGF-1 splicing toward MGF and raises muscle cross-sectional area in elderly subjects (19). Those are review articles. The human work behind them is expression and biopsy data like the studies above.

The cell data cut the other way. The human E-peptide effect on proliferative life appeared in neonatal and young adult cells but not in older adult cells (14). In mice, brain MGF declines with age. Mice engineered to overexpress it from 1 or 3 months had more new neurons in the olfactory bulb at 24 months, but not when overexpression began at 12 months (8). That is gene overexpression. No peptide was given.

What have animal studies found?

In a gerbil model of brain ischemia, a synthetic MGF C-terminal peptide protected vulnerable neurons (9). In sheep after an induced heart attack, the MGF E domain preserved cardiac function and left 35% less compromised muscle (10). In mice, E-domain peptide variants depressed systolic and diastolic function at the lowest and highest of three doses over two weeks (11).

In mice with a muscle contusion and depleted macrophages, injecting MGF did not protect muscle fiber regeneration. It did reduce fibrosis and lowered inflammatory and matrix-metalloproteinase markers (7). We found no MGF peptide study in tendon, ligament or bone.

Is there any human evidence?

No. ClinicalTrials.gov lists no trial of MGF (3). The human data are biopsy studies of natural MGF mRNA. The exercise studies are often cited as human evidence for MGF peptides, but they measured gene expression after lifting or damage. Nothing in them involved giving a synthetic version.

MGF vs IGF-1

Mature IGF-1 is the same in both forms. In the replication study, every cell type responded to mature IGF-1 or full-length IGF-1Eb, and none responded to the MGF peptide (16).

MGF safety

No human safety study exists, so side effects are unknown. MGF comes from the IGF-1 gene, and higher circulating IGF-1 is associated with cancer risk. In UK Biobank (394,388 people), each 5 nmol/L higher IGF-1 went with higher risk of thyroid (HR 1.18), breast (1.11), prostate (1.08) and colorectal cancer (1.08), and lower risk of ovarian and liver cancer. Mean follow-up was 6.9 years, and the authors say reverse causality cannot be excluded (20).

That does not show that MGF raises cancer risk, because nobody has tested it. Goldspink’s group argues the peptide avoids the cancer concern attached to IGF-1 (14), but that is an argument and not a safety result. Anyone with a cancer history should talk to a clinician. The mouse heart result above is a caution about the class of peptides.

Is MGF legal, and is it banned in sport?

FDA has not approved MGF. Its 503A list places mechano growth factor in Category 3, nominated without adequate support (21). PEG-MGF sits on the nominated-but-withdrawn list with an immunogenicity warning (22). WADA’s 2026 Prohibited List names “Mechano growth factors (MGFs)” under S2, which is prohibited at all times (23). A “research use only” label is a seller’s wording and does not make human use legal.

How to judge an MGF listing

A certificate of analysis describes one lot. For a peptide it has to show identity as well as purity. Our peptide COA walkthrough goes through each step.

1. Find a named lab you can search.
2. Match the lot number on the vial to the report.
3. Read the measured mass and compare it with the peptide the listing names.
4. Look for an amount found, because purity alone does not give one.

Red flags are promised muscle gains, injection instructions on the product page, and a report for IGF-1 offered as proof of MGF. Our peptide vendor comparison covers sellers.

MGF questions

MGF is a research chemical for laboratory use only. It is not approved by FDA as a drug or dietary supplement and is not intended to diagnose, treat, cure or prevent any disease.